Intermediate results of the prospective randomized controlled trial VOG-01: "Evaluation of the efficacy of neoadjuvant combination hormone therapy in premenopausal patients with ER+ HER2- breast cancer". Вопр. онкол. [Internet]. 2022 Jul. 6 [cited 2026 Oct. 14];68(3):354-61. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1468